1.
Repetto F, Burzi L, Ribero S, Quaglino P, Dapavo P. Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series. Acta Derm Venereol [Internet]. 2022 Sep. 28 [cited 2024 Sep. 22];102:adv00780. Available from: https://medicaljournalssweden.se/actadv/article/view/2926